S. Africa Pension Investor May Have Dealt CFR's Adcock Buy Fatal Blow
This article was originally published in PharmAsia News
Adcock Ingram's largest stakeholder said it would not agree to even a sweetened deal that would allow Chile's CFR Pharmaceuticals to acquire the South Africa drug maker for $1.23 billion.
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.